Wealth Architects, LLC Corcept Therapeutics Inc Transaction History

Wealth Architects, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	BUY	$19.2 - $24.47 $188,697 - $240,491	9,828 New	9,828 $212,000
Q2 2022 Jul 29, 2022	BUY	$17.33 - $25.3 $519 - $759	30 Added 0.3%	10,005 $238,000
Q1 2022 May 17, 2022	BUY	$16.53 - $25.21 $164,886 - $251,469	9,975 New	9,975 $225,000
Q3 2021 Nov 09, 2021	SELL	$19.68 - $22.53 $243,835 - $279,146	-12,390 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$19.97 - $24.43 $678 - $830	34 Added 0.28%	12,390 $273,000
Q1 2021 Apr 29, 2021	SELL	$23.49 - $30.56 $822 - $1,069	-35 Reduced 0.28%	12,356 $294,000
Q4 2020 Jan 28, 2021	SELL	$16.78 - $27.3 $50 - $81	-3 Reduced 0.02%	12,391 $324,000
Q3 2020 Nov 09, 2020	BUY	$12.46 - $19.98 $149 - $239	12 Added 0.1%	12,394 $216,000
Q1 2020 Apr 23, 2020	BUY	$10.11 - $14.04 $727 - $1,010	72 Added 0.58%	12,382 $147,000
Q4 2019 Jan 28, 2020	SELL	$12.06 - $16.96 $42,813 - $60,208	-3,550 Reduced 22.38%	12,310 $149,000
Q3 2019 Oct 23, 2019	BUY	$10.41 - $14.66 $165,102 - $232,507	15,860 New	15,860 $224,000
Q2 2019 Jul 12, 2019	SELL	$9.78 - $12.76 $155,110 - $202,373	-15,860 Closed	0 $0
Q3 2018 Oct 04, 2018	BUY	$12.27 - $15.65 $552 - $704	45 Added 0.28%	15,860 $222,000
Q2 2017 Aug 10, 2017	BUY	N/A	15,815	15,815 $186,000

403

84.3M

1.04M

1.33M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.81B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Wealth Architects, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Architects, LLC with notifications on news.